Page last updated: 2024-08-24

diphenylcyclopropenone and Chronic Disease

diphenylcyclopropenone has been researched along with Chronic Disease in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (9.09)	18.7374
1990's	3 (27.27)	18.2507
2000's	4 (36.36)	29.6817
2010's	2 (18.18)	24.3611
2020's	1 (9.09)	2.80

Authors

Authors	Studies
Abedini, R; Aryanian, Z; Daneshmand, R; Ghandi, N; Hatami, P; Nasimi, M; Vance, TM	1
Abdelshafy, AS; Esawy, AM; Ibrahim, SA	1
Ma, LQ; Peng, YZ; Shen, FY; Wang, B; Wang, ZR; Wen, W; Zhang, TT; Zhao, X	1
Alkaabi, J; Galadari, H; Galadari, I; Rubaie, S	1
Hamada, R; Ikeda, M; Kodama, H; Seike, M	1
Abbott, F; Ho, V; Shapiro, J; Tan, J; Tron, V	1
Shapiro, J	1
Buckley, DA; Du Vivier, AW; Fuller, LC; Higgins, EM; Keane, FM; Munn, SE	1
Caracciolo, E; Chimenti, S; Cotellessa, C; Mordenti, C; Peris, K	1
Bathgate, A; Bellamy, C; Dollinger, M; Hayes, P; Plevris, J	1
Orecchia, G; Rabbiosi, G	1

Reviews

1 review(s) available for diphenylcyclopropenone and Chronic Disease

Article	Year
Topical immunotherapy in the treatment of chronic severe alopecia areata. Dermatologic clinics, 1993, Volume: 11, Issue:3 Topics: Administration, Topical; Allergens; Alopecia Areata; Chronic Disease; Cyclobutanes; Cyclopropanes; Dinitrochlorobenzene; Hair; Humans; Immunotherapy	1993

Trials

4 trial(s) available for diphenylcyclopropenone and Chronic Disease

Article	Year
A randomized trial of diphenylcyclopropenone (DPCP) combined with anthralin versus DPCP alone for treating moderate to severe alopecia areata. International immunopharmacology, 2021, Volume: 99 Topics: Adolescent; Adult; Age of Onset; Alopecia Areata; Anthralin; Chronic Disease; Cyclopropanes; Drug Therapy, Combination; Female; Hair; Humans; Immunotherapy; Male; Middle Aged; Nail Diseases; Prospective Studies; Treatment Outcome; Young Adult	2021
Diphenylcyclopropenone (diphencyprone, DPCP) in the treatment of chronic severe alopecia areata (AA). European annals of allergy and clinical immunology, 2003, Volume: 35, Issue:10 Topics: Administration, Topical; Adolescent; Adult; Alopecia Areata; Child; Chronic Disease; Cyclopropanes; Female; Humans; Immunotherapy; Male; Middle Aged; Treatment Outcome	2003
Treatment of chronic severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: a clinical and immunopathologic evaluation. Journal of the American Academy of Dermatology, 1993, Volume: 29, Issue:5 Pt 1 Topics: Administration, Cutaneous; Adult; Aged; Alopecia; Antibodies, Monoclonal; Antigens, CD; CD4 Antigens; CD8 Antigens; Cell Adhesion Molecules; Chronic Disease; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Immunophenotyping; Intercellular Adhesion Molecule-1; Keratinocytes; Langerhans Cells; Male; Middle Aged; Minoxidil; Severity of Illness Index; T-Lymphocyte Subsets	1993
The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata. Journal of the American Academy of Dermatology, 2001, Volume: 44, Issue:1 Topics: Administration, Topical; Adolescent; Adult; Alopecia Areata; Chronic Disease; Cyclopropanes; Female; Humans; Male; Middle Aged; Treatment Outcome	2001

Other Studies

6 other study(ies) available for diphenylcyclopropenone and Chronic Disease

Article	Year
Treatment of chronic extensive alopecia areata by diphenylcyclopropenone alone versus in combination with anthralin. Dermatologic therapy, 2019, Volume: 32, Issue:5 Topics: Administration, Topical; Adolescent; Adult; Alopecia Areata; Anthralin; Child; Child, Preschool; Chronic Disease; Cyclopropanes; Dermatologic Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Hair; Humans; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Young Adult	2019
Potentiation of synaptic transmission in Rat anterior cingulate cortex by chronic itch. Molecular brain, 2016, 07-29, Volume: 9, Issue:1 Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Behavior, Animal; Chronic Disease; Cyclopropanes; Disease Models, Animal; Excitatory Postsynaptic Potentials; Gyrus Cinguli; N-Methylaspartate; Neurons; Pruritus; Rats, Sprague-Dawley; Receptors, AMPA; Synaptic Transmission; Up-Regulation	2016
Alteration of sensorineural circuits in spinal cord by chronic contact dermatitis. Somatosensory & motor research, 2005, Volume: 22, Issue:3 Topics: Animals; Behavior, Animal; Calcium-Binding Proteins; Chronic Disease; Coloring Agents; Cyclopropanes; Dermatitis, Contact; Foot; Gene Expression; Genes, fos; Immunohistochemistry; Mice; Mice, Inbred BALB C; Nerve Net; Neuropeptides; Posterior Horn Cells; Reaction Time; Spinal Cord; Up-Regulation	2005
Recalcitrant viral warts treated by diphencyprone immunotherapy. The British journal of dermatology, 1999, Volume: 141, Issue:2 Topics: Adolescent; Adult; Aged; Child; Chronic Disease; Cyclopropanes; Female; Foot Dermatoses; Hand Dermatoses; Humans; Immunotherapy; Male; Middle Aged; Recurrence; Treatment Outcome; Warts	1999
Contact sensitization pretransplantation predicts acute hepatic allograft rejection. Hepatology (Baltimore, Md.), 2001, Volume: 33, Issue:5 Topics: Acute Disease; Adrenal Cortex Hormones; Chronic Disease; Cyclopropanes; Dermatitis, Contact; Follow-Up Studies; Graft Rejection; Humans; Immunization; Liver Diseases; Liver Transplantation; Middle Aged; Prognosis; Skin Tests; Transplantation, Homologous	2001
Treatment of alopecia areata with diphencyprone. Dermatologica, 1985, Volume: 171, Issue:3 Topics: Adolescent; Adult; Alopecia Areata; Child; Chronic Disease; Cyclopropanes; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Male; Middle Aged	1985